What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Echelard sold 10,000 shares of TG Therapeutics. The total transaction amounted to $369,400. In the ...

Investing.com -- Dyne Therapeutics, Inc. (Nasdaq:DYN) stock fell 23% after the company announced an updated plan for obtaining U.S. Accelerated Approval for DYNE-101 in myotonic dystrophy type 1 (DM1) ...

Rosenthal said the Giants’ history of swinging and missing on high-profile sluggers — specifically naming the missed trade ...